ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Significant Expense Categories (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Segment Reporting [Line Items] | ||||||
| Revenue | $ 0 | $ 1,300 | $ 0 | $ 1,300 | ||
| Research and development expense | ||||||
| Total research and development expense | (23,899) | (22,267) | (49,116) | (59,144) | ||
| General and administrative expense | ||||||
| Total general and administrative expense | (8,250) | (6,422) | (13,960) | (12,446) | ||
| Other expense | (4,498) | (1,263) | (7,012) | (1,673) | ||
| Provision for income taxes | (3) | (2) | (3) | (2) | ||
| Net loss | (36,650) | $ (33,441) | (28,654) | $ (43,311) | (70,091) | (71,965) |
| Reportable Segment | ||||||
| Segment Reporting [Line Items] | ||||||
| Revenue | 0 | 1,300 | 0 | 1,300 | ||
| Research and development expense | ||||||
| Personnel | (8,017) | (8,637) | (16,543) | (17,963) | ||
| Clinical trials | (5,285) | (4,082) | (14,465) | (17,347) | ||
| Contract manufacturing | (5,418) | (3,828) | (7,461) | (12,378) | ||
| Equipment, depreciation, and facility | (2,489) | (2,563) | (5,051) | (5,146) | ||
| Other research and development | (2,690) | (3,157) | (5,596) | (6,310) | ||
| General and administrative expense | ||||||
| Personnel | (4,073) | (3,655) | (7,720) | (7,432) | ||
| Other general and administrative | (4,177) | (2,767) | (6,240) | (5,014) | ||
| Total general and administrative expense | (8,250) | (6,422) | (13,960) | (12,446) | ||
| Other expense | (4,498) | (1,263) | (7,012) | (1,673) | ||
| Provision for income taxes | $ (3) | $ (2) | $ (3) | $ (2) | ||
| X | ||||||||||
- Definition General And Administrative Expense, Personnel No definition available.
|
| X | ||||||||||
- Definition Research And Development Expense, Clinical Trials No definition available.
|
| X | ||||||||||
- Definition Research And Development Expense, Contract Manufacturing No definition available.
|
| X | ||||||||||
- Definition Research And Development Expense, Equipment, Depreciation, And Facility No definition available.
|
| X | ||||||||||
- Definition Research And Development Expense, Personnel No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|